AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
French molten salt reactor developer Stellaria has signed a letter of intent with the Alternative Energies & Atomic Energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results